![](https://www.Immune-System-Research.com/"wp-content/uploads"/2021/01/GSK620-is-a-Potent-and-Orally-Active-pan-BET-BD2-Inhibitor-2020-01-08.jpg)
The therapeutic potential of extra terminal domain inhibitor (iBET) has increasing studies both in oncology and immunoinflammatory. Moreover, iBETs are…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2020/07/RVX-297-is-an-Orally-Bioavailable-and-Selective-BET-BD2-Inhibitor-2020-07-22.jpg)
Proinflammatory stimuli induce rapid transcriptional responses. They are essential for host defense from infection. An inflammatory response involves a variety…